Open Journal of Endocrine and Metabolic Diseases

Vol.8 No.8(2018), Paper ID 89038, 10 pages

DOI:10.4236/ojemd.2018.88016

 

Immunogenicity, Safety and Efficacy Comparison of Wockhardt’s Biosimilar Insulin Glargine—Glaritus® with Reference Product— Lantus®: Study Protocol & Early Data Trends

 

S. K. Sharma, A. K. Ajmani, P. Khosla, P. Mukhopadhyay, G. Bhatia, K. G. Prakash, G. Chhaya, P. D. Supe, V. Pavithran, H. Bora, R. Jain, S. Ingole, A. Shah

 

Diabetes, Thyroid and Endocrine Centre, Jaipur, India
BL Kapoor Hospital, Delhi, India
Sir Ganga Ram Hospital, Delhi, India
Institute of Post Graduate Medical Education and Research, Kolkata, India
Medipoint Hospitals Pvt. Ltd., Pune, India
Bangalore Medical College and Research Institute, Bangalore, India
Sanjivani Supers Peciality Hospital, Ahmedabad, India
Supe Heart and Diabetes Hospital and Research Centre, Nashik, India
KVM Hospital, Kerala, India
Downtown Hospital, Guwahati, India
Wockhardt Ltd., Mumbai, India
Wockhardt Ltd., Mumbai, India
Wockhardt Ltd., Mumbai, India

 

Copyright © 2018 S. K. Sharma, A. K. Ajmani, P. Khosla, P. Mukhopadhyay, G. Bhatia, K. G. Prakash, G. Chhaya, P. D. Supe, V. Pavithran, H. Bora, R. Jain, S. Ingole, A. Shah et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article


Sharma, S. , Ajmani, A. , Khosla, P. , Mukhopadhyay, P. , Bhatia, G. , Prakash, K. , Chhaya, G. , Supe, P. , Pavithran, V. , Bora, H. , Jain, R. , Ingole, S. and Shah, A. (2018) Immunogenicity, Safety and Efficacy Comparison of Wockhardt’s Biosimilar Insulin Glargine—Glaritus® with Reference Product— Lantus®: Study Protocol & Early Data Trends. Open Journal of Endocrine and Metabolic Diseases, 8, 157-166. doi: 10.4236/ojemd.2018.88016.

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.